Schonfeld Strategic Advisors’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-249,872
Closed -$18.9M 2776
2026
Q1
$18.9M Sell
249,872
-549,516
-69% -$41.3M 0.13% 168
2025
Q4
$59.5M Buy
799,388
+783,256
+4,855% +$57.2M 0.26% 45
2025
Q3
$1.09M Buy
+16,132
New +$1.07M 0.01% 1320
2025
Q2
Sell
-73,344
Closed -$4.53M 2247
2025
Q1
$4.53M Buy
73,344
+46,124
+169% +$3.06M 0.03% 557
2024
Q4
$1.96M Buy
27,220
+8,945
+49% +$699K 0.01% 842
2024
Q3
$1.49M Buy
18,275
+1,137
+7% +$90.9K 0.01% 1019
2024
Q2
$1.27M Buy
17,138
+13,968
+441% +$1.05M 0.01% 1100
2024
Q1
$247K Sell
3,170
-212,493
-99% -$15.8M ﹤0.01% 1720
2023
Q4
$15.4M Buy
215,663
+208,936
+3,106% +$14.5M 0.1% 230
2023
Q3
$467K Buy
6,727
+3,315
+97% +$251K ﹤0.01% 1222
2023
Q2
$276K Buy
+3,412
New +$279K ﹤0.01% 1423
2022
Q4
Sell
-18,300
Closed -$1.18M 2777
2022
Q3
$1.18M Buy
+18,300
New +$1.27M 0.01% 1164
2022
Q2
Sell
-47,358
Closed -$3.64M 2733
2022
Q1
$3.64M Buy
+47,358
New +$3.41M 0.03% 534
2021
Q1
Sell
-9,600
Closed -$700K 1933
2020
Q4
$700K Sell
9,600
-9,700
-50% -$685K 0.01% 926
2020
Q3
$1.28M Sell
19,300
-13,843
-42% -$876K 0.02% 636
2020
Q2
$1.89M Buy
33,143
+318
+1% +$15.6K 0.05% 426
2020
Q1
$1.15M Buy
32,825
+23,625
+257% +$1.12M 0.07% 321
2019
Q4
$480K Sell
9,200
-32,200
-78% -$1.6M 0.01% 761
2019
Q3
$2.09M Buy
41,400
+33,768
+442% +$1.66M 0.06% 307
2019
Q2
$366K Buy
+7,632
New +$353K 0.01% 722
2019
Q1
Sell
-49,897
Closed -$2.05M 1119
2018
Q4
$2.05M Buy
+49,897
New +$2.05M 0.08% 322
2017
Q4
Sell
-58,647
Closed -$2.15M 796
2017
Q3
$2.15M Sell
58,647
-81,356
-58% -$3.28M 0.2% 146
2017
Q2
$6.35M Sell
140,003
-99,288
-41% -$4.38M 0.66% 27
2017
Q1
$10.2M Buy
239,291
+22,606
+10% +$922K 1.02% 8
2016
Q4
$8.69M Buy
+216,685
New +$8.36M 1.13% 7
2016
Q2
Sell
-19,974
Closed -$689K 473
2016
Q1
$689K Buy
+19,974
New +$697K 0.28% 98

Other funds holding HOLX

Schonfeld Strategic Advisors's HOLX Position: Q2 2026 in Review

Schonfeld Strategic Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 249,872 shares — an estimated $18.9M sold.

Schonfeld Strategic Advisors first reported a position in HOLX in Q1 2016 and held it in 26 quarters. The position peaked at $59.5M in Q4 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Schonfeld Strategic Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 249,872 Hologic shares in Q2 2026, an estimated $18.9M.
  • Schonfeld Strategic Advisors first reported a position in Hologic in Q1 2016 and held it in 26 quarters.
  • Schonfeld Strategic Advisors's Hologic position peaked at $59.5M in Q4 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.